MPM's SunStates Fund Invests $3M into InformedDNA, Acquires Minority Stake | GenomeWeb

NEW YORK (GenomeWeb News) – Life science investment firm MPM Capital's SunStates Fund has acquired a minority stake in InformedDNA with a $3 million investment, the genetic counseling and genetic benefits management services firm announced today.

The investment will be used by InformedDNA to expand its genetic benefits utilization management offerings and to develop new specialty genetic services for the drug manufacturing sector, the St. Petersburg, Fla.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.